cefoperazone has been researched along with Airflow Obstruction, Chronic in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Faber, M; Jahnz-Rózyk, K; Mamełka, B; Targowski, T | 1 |
1 trial(s) available for cefoperazone and Airflow Obstruction, Chronic
Article | Year |
---|---|
[Comparative analysis of the effectiveness and costs of azithromycin and cefoperazone treatment of patients during COPD exacerbation].
Topics: Acute Disease; Adult; Aged; Anti-Bacterial Agents; Azithromycin; Cefoperazone; Chi-Square Distribution; Cost-Benefit Analysis; Dose-Response Relationship, Drug; Double-Blind Method; Drug Costs; Female; Humans; Length of Stay; Male; Middle Aged; Poland; Pulmonary Disease, Chronic Obstructive; Respiratory Function Tests; Time Factors; Treatment Outcome | 2003 |